Long-term effect of obstructive sleep apnea management on blood pressure in patients with resistant hypertension: The SARAH study.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Torres, Gerard
  • Sanchez-de-la-Torre, Manuel
  • Gracia-Lavedan, Esther
  • Benitez, Ivan D
  • Martinez, Dolores
  • Dalmases, Mireia
  • Pinilla, Lucia
  • Minguez, Olga
  • Vaca, Rafaela
  • Pascual, Lydia
  • Aguila, Maria
  • Cortijo, Anunciacion
  • Gort, Clara
  • Mediano, Olga
  • Romero Peralta, Sofia
  • Fortuna-Gutierrez, Ana Maria
  • Ponte Marquez, Paola
  • Drager, Luciano F
  • Cabrini, Mayara
  • de Barros, Silvana
  • Masa, Juan Fernando
  • Corral Penafiel, Jaime
  • Felez, Miguel
  • Vazquez, Susana
  • Abad, Jorge
  • Garcia-Rio, Francisco
  • Casitas, Raquel
  • Lee, Chi-Hang
  • Barbe, Ferran

Grupos

Abstract

There is a close relationship between obstructive sleep apnea (OSA) and resistant hypertension (RH). However, studies assessing the long-term effect of diagnosing and treating OSA on blood pressure (BP) control in these patients are lacking. To address this gap, we recruited 478 RH patients from hypertension units and followed them prospectively after they were screened for OSA through a sleep study. By performing 24-hour ambulatory BP monitoring (24-h ABPM) annually, the effect of OSA management was assessed. The patients had a median age of 64 [57.2; 69.0] years, 67% were males, and most were nonsleepy, with a median apnea-hypopnea index (AHI) of 15.8 [7.9; 30.7] events/hour. The median follow-up time was 3.01 [2.93; 3.12] years. At baseline, severe OSA was associated with uncontrolled BP, nocturnal hypertension, and a nondipper circadian BP pattern. Moreover, these patients had higher BP values during follow-up than did patients in the other groups. However, among patients with moderate and severe OSA, the management of sleep-disordered breathing, including the implementation of CPAP treatment, was associated with a reduction in 24-h ABPM parameters, especially nighttime BP values, at the one-year follow-up. These benefits were attenuated over time, and only subjects with severe OSA maintained an ABPM nighttime reduction at three years. Furthermore, clinical variables such as uncontrolled BP, sex and age showed a predictive value for the BP response at one year of follow-up. In conclusion, a favorable long-term decrease in BP was detected by diagnosing and treating OSA in a cohort of RH patients from hypertension units, but over time, this decrease was only partially maintained in severe-OSA patients (NCT03002558).

Copyright ©The authors 2024. For reproduction rights and permissions contact permissions@ersnet.org.

Datos de la publicación

ISSN/ISSNe:
0903-1936, 1399-3003

EUROPEAN RESPIRATORY JOURNAL  EUROPEAN RESPIRATORY SOC JOURNALS LTD

Tipo:
Article
Páginas:
-
PubMed:
39060017
Factor de Impacto:
4,336 SCImago
Cuartil:
Q1 SCImago

Documentos

  • No hay documentos

Métricas

Filiaciones

Filiaciones no disponibles

Keywords

  • POSITIVE AIRWAY PRESSURE; METAANALYSIS; BP; ASSOCIATION; PREVALENCE; PROGNOSIS; MORTALITY; DISEASE; CPAP

Campos de Estudio

Proyectos y Estudios Clínicos

INTENSIFICACION DR. MIGUEL MARTINEZ GARCIA

Investigador Principal: MIGUEL ÁNGEL MARTÍNEZ GARCÍA

INT11/037 . 2012

ASOCIACION ENTRE TRASTORNOS RESPIRATORIOS DEL SUEÑO Y TASA DE CRECIMIENTO DEL MELANOMA CUTANEO

Investigador Principal: MIGUEL ÁNGEL MARTÍNEZ GARCÍA

PI12/01363 . INSTITUTO DE SALUD CARLOS III . 2013

EFECTO DEL TRATAMIENTO CON CPAP SOBRE LAS CIFRAS TENSIONALES EN PACIENTES CON HIPERTENSION ARTERIAL REFRACTARIA. ESTUDIO MULTICENTRICO Y ALEATORIZADO. ESTUDIO HIPARCO

Investigador Principal: MIGUEL ÁNGEL MARTÍNEZ GARCÍA

PI09/01647 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2010

INTENSIFICACION DR. MIGUEL ANGEL MARTINEZ GARCIA

Investigador Principal: MIGUEL ÁNGEL MARTÍNEZ GARCÍA

INT14/00003 . INSTITUTO DE SALUD CARLOS III . 2015

ASOCIACIÓN ENTRE LOS TRASTORNOS RESPIRATORIOS DEL SUEÑO Y EL PRONÓSTICO DEL MELANOMA. ESTUDIO LONGITUDINAL Y MULTICÉNTRICO EN 443 PACIENTES CON MELANOMA CUTÁNEO MALIGNO.

Investigador Principal: MIGUEL ÁNGEL MARTÍNEZ GARCÍA

PI16/01772 . INSTITUTO DE SALUD CARLOS III . 2017

P4COPD: Prediction, Prevention, Personalized and Precision management of COPD in young adults.

Investigador Principal: MIGUEL ÁNGEL MARTÍNEZ GARCÍA

PMP21/00090 . INSTITUTO DE SALUD CARLOS III . 2022

Contratos Río Hortega 2023. GRACE JACQUELINE OSCULLO YÉPEZ

Investigador Principal: MIGUEL ÁNGEL MARTÍNEZ GARCÍA

CM23/00015 . INSTITUTO DE SALUD CARLOS III . 2024

Registro nacional de antibóticos inhalados en patología crónica de la vía área.

Investigador Principal: MIGUEL ÁNGEL MARTÍNEZ GARCÍA

REPAIR . 2023

Cita

Compartir